Hematology (Amsterdam, Netherlands) · 2026
Effects of long-term cryopreservation at -80 °C on the viability and recovery of peripheral blood stem cells.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Akagi Tomoaki, Ebina Toru, Meguro Fuyuki, Sakamoto Mitsuki, Nihonyanagi Tomoko, Tachita Takuto, Kubo Kohmei
Аннотация
OBJECTIVES: Ensuring the long-term stability of cryopreserved peripheral blood stem cells (PBSCs) is critical for optimal patient outcomes. However, it remains unclear how long-term cryopreservation at -80 °C without controlled-rate freezing in a mechanical freezer affects these cells. Temperature changes may damage cells, reducing their viability. Therefore, in this study, we investigated the effects of long-term storage and the presence of other cells on the viability and recovery of cryopreserved PBSCs.
METHODS: Autologous and allogeneic PBSC samples (n = 115) were cryopreserved at -80 °C in a mechanical freezer without controlled-rate freezing. Subsequently, CD34+ cell viability and recovery were evaluated after storage for up to 60 months using flow cytometry. The effects of co-existing blood cells on the cryopreservation of CD34+ cells were also examined.
RESULTS: Cryopreservation for <24 months did not significantly reduce the viability and recovery of CD34+ cells, while decreases were observed following storage for >24 months. Further, cryopreservation with ≥10% granulocytes decreased CD34+ cell viability and recovery.
DISCUSSION: The present findings suggest that storage beyond 24 months and containing a high proportion of granulocytes may have a negative impact on CD34⁺ cell viability and recovery. Attention to storage duration and contaminating cell populations could help support more stable outcomes during cryopreservation at -80 °C.
CONCLUSIONS: The cryopreservation conditions employed in this study did not significantly reduce CD34+ cell viability and recovery during storage for up to 24 months. A higher granulocyte content was associated with lower post-thaw CD34+ viability and recovery.
METHODS: Autologous and allogeneic PBSC samples (n = 115) were cryopreserved at -80 °C in a mechanical freezer without controlled-rate freezing. Subsequently, CD34+ cell viability and recovery were evaluated after storage for up to 60 months using flow cytometry. The effects of co-existing blood cells on the cryopreservation of CD34+ cells were also examined.
RESULTS: Cryopreservation for <24 months did not significantly reduce the viability and recovery of CD34+ cells, while decreases were observed following storage for >24 months. Further, cryopreservation with ≥10% granulocytes decreased CD34+ cell viability and recovery.
DISCUSSION: The present findings suggest that storage beyond 24 months and containing a high proportion of granulocytes may have a negative impact on CD34⁺ cell viability and recovery. Attention to storage duration and contaminating cell populations could help support more stable outcomes during cryopreservation at -80 °C.
CONCLUSIONS: The cryopreservation conditions employed in this study did not significantly reduce CD34+ cell viability and recovery during storage for up to 24 months. A higher granulocyte content was associated with lower post-thaw CD34+ viability and recovery.